HRH4 and breast carcinoma: To improve our knowledge on the role of H4R in histamine-mediated responses, the effect of an H4R agonist (JNJ28) and an H4R antagonist (JNJ77) was evaluated in vivo by employing the 4T1 breast cancer model.